与乳腺癌患者共同决策——是否有效?集群随机多中心DBCG RT SDM试验结果
该集群随机多中心试验将四个放疗单位的肿瘤科医生随机分为使用决策辅助工具(DH)进行共同决策(SDM)组与常规实践组,纳入674例保乳术后淋巴结阴性乳腺癌患者。DH组患者报告的决策参与度(SDM-Q-9中位数80)高于对照组(71.1,p<0.0001),医生报告的患者参与度也更高。DH现已被丹麦指南推荐为辅助全乳放疗的标准治疗。
要点
- 使用决策辅助工具(DH)进行共同决策可提高患者报告的决策参与度(SDM-Q-9中位数80 vs 71.1,p<0.0001)。
- 医生报告的患者参与度在DH组也更高(中位数93.3 vs 73.3,p<0.0001)。
- DH已被丹麦指南推荐为辅助全乳放疗的标准治疗。
核心结论
- 与标准实践相比,使用问诊中的患者决策辅助工具显著改善了患者在医疗决策中的参与度。
- DH现已被丹麦指南推荐为辅助全乳放疗的标准治疗。
研究设计与样本
- 集群随机多中心试验,四个放疗单位的肿瘤科医生被随机分为使用DH进行SDM组与常规实践组。
- 纳入保乳术后淋巴结阴性乳腺癌、适合辅助全乳放疗的患者,共674例。
主要发现
- 674例中635例(94.2%)完成了SDM-Q-9。
- 干预组患者报告的参与度中位数80(IQR 68.9-94.4),对照组71.1(IQR 55.6-82.2),p<0.0001。
- 医生报告的患者参与度干预组中位数93.3(IQR 82.2-100),对照组73.3(IQR 60.0-84.4),p<0.0001。
关键数值与推荐
- 主要终点为患者报告的决策过程参与度,采用SDM-Q-9评估(范围0-100,4分差异被认为有临床相关性)。
- 其他终点包括医生报告的患者参与度、决策冲突、癌症复发恐惧及6个月后的决策后悔。
临床怎么用
- 原文结论指出DH已被丹麦指南推荐为辅助全乳放疗的标准治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Shared decision making (SDM) is a patient engaging process advocated especially for preference-sensitive decisions, such as adjuvant treatment after breast cancer. An increasing call for patient engagement in decision making highlights the need for a systematic SDM approach. The objective of this trial was to investigate whether the Decision Helper (DH), an in-consultation patient decision aid, increases patient engagement in decisions regarding adjuvant whole breast irradiation. MATERIAL AND METHODS: Oncologists at four radiotherapy units were randomized to practice SDM using the DH versus usual practice. Patient candidates for adjuvant whole breast irradiation after breast conserving surgery for node-negative breast cancer were eligible. The primary endpoint was patient-reported engagement in the decision process assessed with the Shared Decision Making Questionnaire (SDM-Q-9) (range 0-100, 4 points difference considered clinical relevant). Other endpoints included oncologist-reported patient engagement, decisional conflict, fear of cancer recurrence, and decision regret after 6 months. RESULTS: Of the 674 included patients, 635 (94.2%) completed the SDM-Q-9. Patients in the intervention group reported higher level of engagement (median 80; IQR 68.9 to 94.4) than the control group (71.1; IQR 55.6 to 82.2; p < 0.0001). Oncologist-reported patient engagement was higher in the invention group (93.3; IQR 82.2 to 100) compared to control group (73.3; IQR 60.0 to 84.4) (p < 0.0001). CONCLUSION: Patient engagement in medical decision making was significantly improved with the use of an in-consultation patient decision aid compared to standard. The DH on adjuvant whole breast irradiation is now recommended as standard of care in the Danish guideline.
引用
- Søndergaard SR, Bechmann T, Maae E, et al. Shared decision making with breast cancer patients - does it work? Results of the cluster-randomized, multicenter DBCG RT SDM trial. Radiother Oncol. 2024. PMID: 38316191. doi:10.1016/j.radonc.2024.110115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。